This seems to indicate a possible role of TRAP-1 as being responsible for multi-drug resistance in human colorectal cancer: TRAP-1 may give us a potential therapeutic target which has important implications for the efficacy of anticancer agents in cancer therapeutics. This evidence concerns the gene TRAP1 and colorectal cancer.